Chemistry coupled with pharmacology, both preclinical and clinical, forms the basis for the pipeline we manage at Ionis today. This presentation will focus on some of the research innovations that are providing the advancing, growing and improving development programs that has been implemented recently. The objective is to provide some insights into the power of chemical and pharmacological research as it attends to the advancements in oligonucleotide-based therapeutics.